Correlation Between Mineralys Therapeutics, and Biomea Fusion
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Biomea Fusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Biomea Fusion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Biomea Fusion, you can compare the effects of market volatilities on Mineralys Therapeutics, and Biomea Fusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Biomea Fusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Biomea Fusion.
Diversification Opportunities for Mineralys Therapeutics, and Biomea Fusion
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mineralys and Biomea is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Biomea Fusion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomea Fusion and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Biomea Fusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomea Fusion has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Biomea Fusion go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Biomea Fusion
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 0.61 times more return on investment than Biomea Fusion. However, Mineralys Therapeutics, Common is 1.64 times less risky than Biomea Fusion. It trades about 0.01 of its potential returns per unit of risk. Biomea Fusion is currently generating about -0.02 per unit of risk. If you would invest 1,616 in Mineralys Therapeutics, Common on August 30, 2024 and sell it today you would lose (305.00) from holding Mineralys Therapeutics, Common or give up 18.87% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Biomea Fusion
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Biomea Fusion |
Mineralys Therapeutics, and Biomea Fusion Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Biomea Fusion
The main advantage of trading using opposite Mineralys Therapeutics, and Biomea Fusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Biomea Fusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomea Fusion will offset losses from the drop in Biomea Fusion's long position.| Mineralys Therapeutics, vs. Ultra Clean Holdings | Mineralys Therapeutics, vs. Playtika Holding Corp | Mineralys Therapeutics, vs. Helmerich and Payne | Mineralys Therapeutics, vs. Capital Clean Energy |
| Biomea Fusion vs. Bright Minds Biosciences | Biomea Fusion vs. HP Inc | Biomea Fusion vs. Intel | Biomea Fusion vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |